1. |
Yamashita M,Yamashita M,Ando Y.A long-term follow-up of lung function in survivors of paraquat poisoning[J].Hum Exp Toxicol,2000,19(2):99-103..
|
2. |
Hwang KY,Lee EY,Hong SY.Paraquat intoxication in Korea[J].Arch Environ Health,2002,57(2):162-166..
|
3. |
Suntres ZE.Role of antioxidants in paraquat toxicity[J].Toxicology,2002,180(1):65-77..
|
4. |
Bianchi M,Fantuzzi G,Bertini R,et al.The pneumotoxicant paraquat induces IL-8 mRNA in human mononuclear cells and pulmonary epithelial cells[J].Cytokine,1993,5(5):525-530..
|
5. |
Barrios R,Pardo A,Ramos C,et al.Upregulation of acidic fibroblast growth factor during development of experimental lung fibrosis[J].Am J Physiol,1997,273(2 Pt 1):L451-L458..
|
6. |
Hong SY,Yang DH,Hwang KY.Associations between laboratory parameters and outcome of paraquat poisoning[J].Toxicol Lett,2000,118(1-2):53-59..
|
7. |
Yamamoto I,Saito T,Harunari N,et al.Correlating the severity of paraquat poisoning with specific hemodynamic and oxygen metabolism variables[J].Crit Care Med,2000,28(6):1877-1883..
|
8. |
Fissell WH,Dyke DB,Weitzel WF,et al.Bioartificial kidney alters cytokine response and hemodynamics in endotoxin-challenged uremic animals[J].Blood Purif,2002,20(1):55-60..
|
9. |
乔林,姜树山,王英元,等.急性百草枯中毒实验病理研究[J].山西医学院学报,1993,24(1):36-39..
|
10. |
李少岩,李洪洋,郑志仁,等.百草枯所致大鼠弥漫性肺损伤的病理特点[J].华西医大学报,1994,25(3):337-340.
|
11. |
Ishida Y,Takayasu T,Kimura A,et al.Gene expression of cytokines and growth factors in the lungs after paraquat administration in mice[J].Leg Med(Tokyo),2006,8(2):102-109..
|
12. |
Tomita M,Okuyama T,Katsuyama H,et al.Paraquat-induced gene expression in rat kidney[J].Arch Toxicol,2006,80(10):687-693..
|
13. |
王质刚,马青,郭王,等.从肾脏角度认识全身炎症反应综合征[J].内科急危重症杂志,2000,6(1):51-53..
|
14. |
Fisher CJ Jr,Agosti JM,Opal SM,et al.Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein.The SolubleTNF Receptor Sepsis Study Group[J].N Engl J Med,1996,334(26):1697-1702.Comment in:N Engl J Med,1996,335(21):1607-1608; author reply 1608-1609..
|
15. |
Pavassilion AG.Transcription factors[J].N Engl J Med,1995,332:45-47..
|
16. |
Paterson RL,Galley HF,Dhillon JK,et al.Increased nuclear factor kappa B activation in critically ill patients who die[J].Crit CareMed,2000,28(4):1047-1051..
|
17. |
Foulds S,Galustian C,Mansfield AO,et al.Transcription factor NF kappa B expression and postsurgical organ dysfunction[J].Ann Surg,2001,233(1):70-78..
|
18. |
Baldwin AS Jr.The NF-kappa B and I kappa B proteins:new discoveries and insights[J].Annu Rev Immunol,1996,14:649-683..
|
19. |
Baeuerle PA,Baltimore D.NF-κB:Ten years after[J].Cell,1996,87(1):13-20..
|
20. |
Baeuerle PA.IkappaB-NF-kappaB structures:at the interface of inflammation control[J].Cell,1998,95(6):729-731;Comment on:749-770..
|
21. |
Baeuerle PA,Baltimore D.I kappa B:a specific inhibitor of the NF-kappa B transcription factor[J].Science,1988,242(4878):540-546..
|
22. |
Kovacich JC,Boyle EM Jr,Morgan EN,et al.Inhibition of the transcriptional activator protein nuclear factor kappaB prevents hemodynamic instability associated with the whole-body inflammatory response syndrome[J].J Thorac Cardiovasc Surg,1999,118(1):154-162..
|
23. |
Baeuerle PA,Baichwal VR.NF-kappa B as a frequent target for immunosuppressive and anti-inflammatory molecules[J].Adv Immunol,1997,65:111-137..
|
24. |
Ryuichi M,Naruya T,Yasufumi K,et al.Molecular therapy to inhibit NF кB activation by transcription factor decoy oligonucleotides[J].Curr Opin Pharmacol,2004,4(2):139-146.
|